Gottlieb anticipates extra resources for drug safety

Share this article:
FDA deputy commissioner for medical and scientific affairs Scott Gottlieb says he is confident additional resources will be allocated for the agency's drug safety efforts in the FY 2008 budget and under its user fee renegotiation (PDUFA 4).

Commenting on a Los Angeles Times report, Gottlieb said some $10 million was added for drug safety last year with more likely to come in the future.

The newspaper reported from interviews and documents on an FDA-funded study meant to answer questions about the drugs for ADHD that may be halted in midstream because the agency lacks funds to finish it.

The threat to the study, the newspaper said, stems from shortchanging of the nation's drug safety program and is a symptom of an agency constrained by a budget that has failed to keep up with costs.

Even as concerns grow, the Times said, the agency has budgeted only $1.6 million for such safety studies of medications already on the market, and that number is scheduled to drop to $900,000 in the coming year.

“Clearly we need additional resources as the complexity of our mission, and the products we regulate, continues to increase,” Gottlieb said.

Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...